alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › journey

journey

3 studies tagged journey, dated 2018-01-01 to 2019-11-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey 2019-11-01
  2. The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth 2018-11-08
  3. Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies 2018-01-01

Studies

3 studies carry this tag.

Date range

2018 to 2019

Top journals

  • British journal of clinical pharmacology 1
  • Journal of Alzheimer's disease : JAD 1
  • Journal of the American Board of Family Medicine : JABFM 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of the American Board of Family Medicine : JABFM 2019-11-01 Biomarkers

    Despite recent setbacks, disease-modifying treatments (DMTs) for Alzheimer disease (AD) might become available within a few years.

  2. The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. British journal of clinical pharmacology 2018-11-08 Drug development

    Our knowledge of the effect of metformin on human health is increasing.

  3. Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of Alzheimer's disease : JAD 2018-01-01 Brain scans and imaging

    Worldwide there are over 46 million people living with dementia, and this number is expected to double every 20 years reaching about 131 million by 2050.

All topic tags with their study counts